Skip to content

Author

J. Tarning

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

In Vitro assessment of clarithromycin and erythromycin depletion in the presence of andrographolide using human liver microsomes

Andrographolide is a major bioactive compound of Andrographis paniculata , a medicinal herb widely used in Asia. Previous in vitro studies have reported effects of andrographolide on CYP3A4 expression and activity. However, potential pharmacokinetic interactions with the macrolide antibiotics clarithromycin a...

Phornpimon Tipthara, S. Apinan, Rattawan Kullasakboonsri et al. · 0 citations
Open access Sep 2026

A pilot study evaluating the tolerability and effectiveness of miltefosine and sodium stibogluconate for the treatment of cutaneous leishmaniasis in Kandahar, Afghanistan

Oral miltefosine (MF) achieves per-protocol cure rates of 68–77% against Leishmania tropica in Iran and Pakistan, but it has never been compared with the standard of care in Afghanistan, where only intralesional (IL) or intramuscular (IM) antimonials are used. We, therefore, assessed the 6-month efficacy and tolerabili...

Bilal Ahmad Rahimi, W. Disphanurat, Khoshal Bakhtialy et al. · 0 citations
#protein folding Oct 2026

PBPK Model-Based Prediction of Optimal Rosuvastatin Dosing with Concomitant Ticagrelor in Elderly Patients Considering ABCG2 Genetic Variant.

Aims Rosuvastatin is commonly co-administered with ticagrelor in patients with acute coronary syndrome. Ticagrelor inhibits breast cancer resistance protein (BCRP/ABCG2), increasing rosuvastatin exposure and potentially the risk of rhabdomyolysis. This risk may be further influenced by age and the ABCG2 c.421C>A varian...

D. H. Nguyen, H. T. V. Pham, J. Ding et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.